skip to main content

DOE PAGESDOE PAGES

Title: Building parity between brand and generic peptide products: Regulatory and scientific considerations for quality of synthetic peptides

Authors:
; ; ; ;
Publication Date:
Type:
Publisher's Accepted Manuscript
Journal Name:
International Journal of Pharmaceutics
Additional Journal Information:
Journal Volume: 518; Journal Issue: 1-2; Related Information: CHORUS Timestamp: 2018-09-05 11:51:05; Journal ID: ISSN 0378-5173
Publisher:
Elsevier
Sponsoring Org:
USDOE
Country of Publication:
Netherlands
Language:
English
OSTI Identifier:
1413839

Wu, Larisa C., Chen, Fu, Lee, Sau L., Raw, Andre, and Yu, Lawrence X.. Building parity between brand and generic peptide products: Regulatory and scientific considerations for quality of synthetic peptides. Netherlands: N. p., Web. doi:10.1016/j.ijpharm.2016.12.051.
Wu, Larisa C., Chen, Fu, Lee, Sau L., Raw, Andre, & Yu, Lawrence X.. Building parity between brand and generic peptide products: Regulatory and scientific considerations for quality of synthetic peptides. Netherlands. doi:10.1016/j.ijpharm.2016.12.051.
Wu, Larisa C., Chen, Fu, Lee, Sau L., Raw, Andre, and Yu, Lawrence X.. 2017. "Building parity between brand and generic peptide products: Regulatory and scientific considerations for quality of synthetic peptides". Netherlands. doi:10.1016/j.ijpharm.2016.12.051.
@article{osti_1413839,
title = {Building parity between brand and generic peptide products: Regulatory and scientific considerations for quality of synthetic peptides},
author = {Wu, Larisa C. and Chen, Fu and Lee, Sau L. and Raw, Andre and Yu, Lawrence X.},
abstractNote = {},
doi = {10.1016/j.ijpharm.2016.12.051},
journal = {International Journal of Pharmaceutics},
number = 1-2,
volume = 518,
place = {Netherlands},
year = {2017},
month = {2}
}